The federal Ready, Set, PrEP program ended July 2025. Many websites still list it as active. See what replaced it →
Comparison

Oral PrEP vs Injectable PrEP (2026): Which Is Right for You?

Published April 17, 2026 · 8 min read

In 2026 you have more PrEP options than ever: a daily pill (oral TDF/FTC, Truvada, or Descovy), an injection every 2 months (Apretude), or a twice-yearly injection (Yeztugo). All three are 99%+ effective when used properly. The question isn't which one works — they all do. The question is which one fits your life. Here's an honest comparison.

The three choices at a glance

Oral PrEP (daily pill)
Generic TDF/FTC, Truvada, or Descovy
Most common
DailySchedule
~$30/moRetail (generic)
14 yearsSafety data
99%+Effective
Apretude (cabotegravir)
Intramuscular injection every 2 months
Long-acting
6x/yearSchedule
~$24K/yrRetail
5 yearsSafety data
99%+Effective
Yeztugo (lenacapavir)
Subcutaneous injection twice a year
Newest
2x/yearSchedule
$28,218/yrRetail
~1 yearPost-approval
~100%Trial efficacy

Oral PrEP — pros and cons

Pros

  • Most studied — 14+ years of safety data
  • Cheapest option (generic ~$30/mo retail)
  • No needles, no clinic visits for administration
  • Easy to stop (no long drug tail)
  • On-demand/"2-1-1" dosing option for MSM
  • Covered on every insurance formulary
  • Works in every FDA-approved population including cisgender women (generic/Truvada)

Cons

  • Requires daily adherence
  • TDF can cause small kidney/bone effects (reversible)
  • Pills must be stored and carried
  • Privacy concerns if living with family who don't know
  • Occasional GI side effects during start-up
  • Descovy isn't approved for vaginal-sex exposure

Injectable PrEP — pros and cons

Pros

  • No daily pill to remember
  • Total adherence removed from your hands — once you show up, you're covered
  • Private (no pills at home)
  • In HPTN 083, Apretude was 69% more effective than daily PrEP in real-world use — entirely an adherence effect
  • Yeztugo is twice-yearly — two visits covers the whole year
  • Easier on kidneys and bones than TDF

Cons

  • Requires clinic visits for each injection
  • Injection site reactions common (mild, temporary)
  • Long drug "tail" — if you stop, levels decline slowly over ~1 year (non-protective during tail)
  • Often requires prior authorization
  • Prescribers who can administer are not universal yet
  • Higher list price (though $0 pathways exist)

Talk to a provider — free consult in all 50 states

MISTR prescribes both oral and injectable PrEP. A provider will walk you through which option fits your health, schedule, and preferences. Medication, labs, and consults are $0 whether you're insured or not.

Use code: ANDR735

Using this code helps keep FreePrEP.org running and connects more people to free PrEP.

Start with MISTR →

Side-by-side: oral vs injectable

Oral (generic TDF/FTC) Apretude (every 2 mo) Yeztugo (twice yearly)
Schedule1 pill dailyInjection every 2 monthsInjection every 6 months
Visits/year~4 (quarterly labs)62
Retail cost (uninsured)~$30/month~$24,000/year$28,218/year
Cost if insured (with assistance)$0$0$0
Effectiveness (real-world)99%+ with perfect adherence~100% in trials~100% in trials
FDA-approved for womenYesYesYes
Side-effect profileSmall kidney/bone effects (TDF)Injection-site reactionsInjection-site reactions
StoppingClean, short washoutLong "tail" (up to 12 months)Long "tail" (several months)
Insurance formularyUniversalWidespread, often PA requiredExpanding, often PA required

Which one should you pick?

Pick oral PrEP if…
Daily pills aren't a problem and you want the cheapest, most-studied option

Oral generic TDF/FTC is the most cost-effective, best-studied PrEP available. If you can reliably take a daily pill — or already do for other meds — oral PrEP is the default recommendation. It's also the easiest to stop if you decide you don't want PrEP anymore, because there's no long tail.

Pick Apretude if…
You've tried daily pills and struggled — or you want privacy at home

Apretude is the go-to when daily adherence is genuinely difficult: unstable housing, traveling frequently, poor memory for daily habits, or living with people you don't want to out yourself to. Six visits a year is more than Yeztugo's two, but Apretude has more real-world insurance coverage right now and is often easier to get approved.

Pick Yeztugo if…
You want the absolute minimum number of healthcare interactions per year

Two injections a year, and you're done. For people who travel, live far from clinics, or simply don't want to think about PrEP between visits, Yeztugo is a generational advance. The main catch is that insurance coverage is still catching up — as of early 2026, some plans require prior authorization or prefer Apretude.

Common situations and what to pick

You're just starting PrEP for the first time

Start with oral generic TDF/FTC unless you have a specific reason not to. It's the cheapest, most-studied, best-covered option. You can always switch to an injectable later if daily adherence becomes a problem.

You keep missing doses

Switch to an injectable. Yeztugo if available in your plan, Apretude if not. Data from HPTN 083 showed Apretude was 69% more effective than daily PrEP in real-world use — not because oral PrEP doesn't work, but because adherence is easier with an injection.

You're traveling frequently or living nomadically

Yeztugo (twice-yearly) is the best fit — two visits a year means you can time them with your travel. Apretude works too but requires more coordination.

You have kidney or bone concerns

Skip TDF-based options. Descovy (oral TAF-based) is easier on kidneys and bones, as are both injectables. Talk to your provider about Descovy, Apretude, or Yeztugo.

You're cost-conscious and uninsured

Generic TDF/FTC through telehealth (MISTR) costs $0 and doesn't require insurance. This is typically the cheapest and fastest path. If you want injectable, Gilead's MAP covers Yeztugo free for uninsured patients under 500% FPL.

You're a cisgender woman at risk through vaginal sex

Generic TDF/FTC or Truvada (oral), Apretude, or Yeztugo. Not Descovy — it isn't FDA-approved for this route of exposure. See PrEP for Women in 2026.

You're pregnant or breastfeeding

Generic TDF/FTC (or Truvada) has the largest safety database during pregnancy and breastfeeding. CDC, WHO, and ACOG all endorse continuing PrEP during pregnancy when at risk.

Still not sure?

Use the eligibility tool — four questions, 60 seconds, no sign-up. We'll match you with every free PrEP option available to you, and flag which might fit best.

Start the Eligibility Tool →

Can you switch between oral and injectable?

Yes. Switching from oral to injectable is straightforward — your provider will schedule your first injection after your current oral regimen. Going the other direction (injectable to oral) is also doable, but you'll need to start oral PrEP before your injectable tail fully decays, to avoid a gap in protection. Your provider will time this.

The answer most people should hear

If you're new to PrEP, pick oral generic TDF/FTC. It's cheap, it works, and it's easy to switch if something changes. If you've been on oral PrEP and daily adherence is becoming a burden, switch to Yeztugo or Apretude — you don't have to earn your way to injectables, and the choice is entirely about fit.

The goal is to be on some form of PrEP if you're at risk. Whichever option gets you there reliably is the right one.

Ready to start (or switch)?

MISTR prescribes oral and injectable PrEP at $0 in all 50 states. Switching between options is easy — one platform, one provider, no extra paperwork.

Use code: ANDR735

Using this code helps keep FreePrEP.org running and connects more people to free PrEP.

Get Started with MISTR →

Information sourced from CDC clinical guidelines, FDA prescribing labels, and the HPTN 083/084, iPrEx, DISCOVER, and PURPOSE 1/2 clinical trials. FreePrEP.org is an independent resource — not affiliated with any government agency or pharmaceutical company. This article is educational, not medical advice. Full disclosure